Peregrine Pharmaceuticals (NASDAQ:PPHM)

CAPS Rating: 1 out of 5

A biopharmaceutical company with a portfolio of clinical stage and pre-clinical product candidates using monoclonal antibodies for the treatment of cancer and viral diseases.

Recs

0
Player Avatar Momentum21 (98.13) Submitted: 8/13/2012 3:26:00 PM : Underperform Start Price: $2.79 PPHM Score: +35.58

thank you very much, I believe I snagged the high of the year with this dog. it is a testament to my dogged determination in trying to game this anything but intuitive CAPS system! as they say...look out below...I spotted a negative divergence on all of the MACD lighting and a RSI indicator that just flipped upside down. It is also falling under double DOJI patterns every 30 seconds. Did you see that skeedaddy?

Featured Broker Partners


Advertisement